Which should you choose? Here's what you need to know.
Retatrutide has the strongest weight loss data of any peptide in clinical trials. 5-Amino-1MQ is a promising NNMT inhibitor, but it has zero human clinical data — mouse studies only.
5-Amino-1MQ blocks the NNMT enzyme to boost cellular energy expenditure. In mice, it reversed diet-induced obesity and improved glucose tolerance. However, no human clinical trials have been conducted.
Choose 5-Amino-1MQ if:
You're interested in a novel fat-burning mechanism and are comfortable with a compound that has only preclinical data.
Retatrutide is a triple receptor agonist (GLP-1/GIP/glucagon) with Phase 3 data showing 28.7% mean weight loss over 68 weeks — the most effective obesity drug ever studied.
Choose Retatrutide if:
You want a weight loss peptide backed by large-scale human clinical trial data.
Once you've decided which peptide fits your needs, here's how they compare on price and vendor options.
Our top-rated vendor for each, based on trust scores, purity testing, and price.
We re-check vendor prices continuously and score vendors on Finnrick blind-test results — samples bought anonymously and sent to a lab, not vendor claims. No vendor can pay to rank higher. See our full methodology.